Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5184290 | 0.90 | ALDH1A1 (0.49) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL5184296 | 0.81 | ALDH1A1 (0.42) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL5183385 | 0.78 | ALDH1A1 (0.41) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL5182392 | 0.77 | PKM (0.46) | ALDH1A1CYP1A2CYP2C19MEN1KMT2A | |
| SCHEMBL6326332 | 0.76 | RAB9A (0.35) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL5182662 | 0.76 | MAPT (0.48) | ALDH1A1CASP1HSD17B10GAAL3MBTL1 | |
| SCHEMBL5183669 | 0.76 | GLA (0.39) | ALDH1A1CYP1A2CYP2C19L3MBTL1MEN1 | |
| SCHEMBL5184321 | 0.75 | ALDH1A1 (0.49) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL5182357 | 0.74 | KMT2A (0.48) | ALDH1A1GAAMAPK1TP53MEN1 | |
| SCHEMBL5222036 | 0.73 | CYP1A2 (0.46) | ALDH1A1CYP1A2CYP2C19HSD17B10GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1301492-B1 | NOVEL TETRAZOLE DERIVATIVES | BAYER CROPSCIENCE KK (JP) | 2007-07-04 | — | — | EP | disclosed |
| US-6770599-B2 | Tetrazole derivatives | BAYER CROPSCIENCE KK (JP) | 2004-08-03 | — | — | US | disclosed |
| US-20030224943-A1 | Novel tetrazole derivatives | BAYER CROPSCIENCE K. K. (JP) | 2003-12-04 | — | — | US | disclosed |
| EP-1301492-A1 | NOVEL TETRAZOLE DERIVATIVES | NIHON BAYER AGROCHEM K.K. (JP) | 2003-04-16 | — | — | EP | disclosed |
| WO-2002002536-A1 | NOVEL TETRAZOLE DERIVATIVES | BAYER CROPSCIENCE K.K. (DE) | 2002-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030224943-A1 | Novel tetrazole derivatives | CBR3, CBR1, ECH1 | ALDH1A1 783/4885CYP1A2 220/4885CYP3A4 453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.